Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
10:05am, Thursday, 13'th Feb 2025
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching U
QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand
07:51am, Friday, 07'th Feb 2025
QGEN's performance benefits from a resilient portfolio in the fourth quarter of 2024.
Qiagen N.V. (QGEN) Q4 2024 Earnings Call Transcript
04:49pm, Thursday, 06'th Feb 2025
Qiagen N.V. (NYSE:QGEN ) Q4 2024 Earnings Conference Call February 6, 2025 10:00 AM ET Company Participants John Gilardi – Vice President, Head of Corporate Communications and Investor Relations Thi
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
07:01pm, Wednesday, 05'th Feb 2025
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Qiagen (QGEN) Q4 Earnings Lag Estimates
06:46pm, Wednesday, 05'th Feb 2025
Qiagen (QGEN) came out with quarterly earnings of $0.61 per share, missing the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.57 per share a year ago.
QIAGEN delivers solid Q4 2024 growth ahead of outlook
04:05pm, Wednesday, 05'th Feb 2025
VENLO, The Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced financial results for the fourth quarter and full-year 2024. Net sale
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
04:05pm, Tuesday, 04'th Feb 2025
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a
Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?
08:31am, Thursday, 30'th Jan 2025
QGEN stays on investors' radar due to its robust expansion of testing menu and benefits from strategic ties.
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Wednesday, 29'th Jan 2025
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strategic Collaborations Aid QGEN Stock Amid Competition
11:41am, Friday, 17'th Jan 2025
QIAGEN invests heavily in research and development to support internal growth, including the menu expansion of its key platforms.
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million
04:05pm, Thursday, 16'th Jan 2025
VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return up to approxima
GMAB vs. QGEN: Which Stock Is the Better Value Option?
12:41pm, Thursday, 16'th Jan 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Genmab A/S Sponsored ADR (GMAB) and Qiagen (QGEN). But which of these two stocks is more
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase
01:05pm, Sunday, 12'th Jan 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new plan to return up to approximately $300 million (maximum EUR 281 mi
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
01:30am, Friday, 10'th Jan 2025
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system wi
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care
04:05pm, Thursday, 09'th Jan 2025
GERMANTOWN, Md., & VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gast
